Eric Gornstein

Radius HealthSenior Director of Insights & Analytics

Eric is a biopharmaceutical commercial and business development executive with broad industry perspective.  He leads commercial insights and analytics efforts for Radius Health's portfolio of medicines in the areas of osteoporosis, oncology, and endocrine diseases.  He joined the company in 2015 as the second commercial employee and helped build the commercial operations organization and infrastructure to launch their first product in the United States. 

Originally trained as a biologist, Eric began his career conducting pediatric genetic research at Boston Children’s Hospital.  He transitioned into pharmaceutical market analysis at Decision Resources.  From there, Eric assumed commercial and buy- and sell-side business development (BD) roles at companies of all sizes--from startups to global majors--including Biogen, Millennium, Acceleron and AstraZeneca.  Before joining Radius, Eric was a Director in Navigant Consulting’s Life Sciences practice, where he led international teams of PhD, MD, and MBA-level consultants on commercial, BD, and financing strategy engagements for global biopharmaceutical clients. 

Eric has a BA with distinction in biology from Boston University, where he was a Trustee Scholar, and an Executive MBA from MIT Sloan School of Management.